From: Trend and determinants of mortality in incident hemodialysis patients of the Lazio region
2008–2010 | 2011–2013 | 2014–2016 | Total | p-value* | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | ||||||
Total | 2,317 | 100.0 | 2,295 | 100.0 | 2,385 | 100.0 | 6,997 | 100.0 | |||||
Gender | 0.241 | ||||||||||||
Male | 1,469 | 63.4 | 1,478 | 64.4 | 1,568 | 65.7 | 4,515 | 64.5 | |||||
Female | 848 | 36.6 | 817 | 35.6 | 817 | 34.3 | 2,482 | 35.5 | |||||
Age (years) | 0.452 | ||||||||||||
< 65 | 782 | 33.8 | 759 | 33.1 | 830 | 34.8 | 2,371 | 33.9 | |||||
≥ 65 | 1,535 | 66.3 | 1,536 | 66.9 | 1,555 | 65.2 | 4,626 | 66.1 | |||||
Site of birth | < 0.001 | ||||||||||||
Italy | 2,155 | 93.0 | 2,108 | 91.9 | 2,151 | 90.2 | 6,414 | 91.7 | |||||
Other countries | 162 | 7.0 | 187 | 8.2 | 234 | 9.8 | 583 | 8.3 | |||||
Residence | 0.825 | ||||||||||||
Rome Municipality | 1,149 | 49.6 | 1,149 | 50.1 | 1,216 | 51.0 | 3,514 | 50.2 | |||||
Rome Province | 557 | 24.0 | 560 | 24.4 | 554 | 23.2 | 1,671 | 23.9 | |||||
Other Lazio’s municipalities | 611 | 26.4 | 586 | 25.5 | 615 | 25.8 | 1,812 | 25.9 | |||||
Education level | < 0.001 | ||||||||||||
Up to Middle School | 1,622 | 70.0 | 1,520 | 66.2 | 1,504 | 63.1 | 4,646 | 66.4 | |||||
High School or more | 695 | 30.0 | 775 | 33.8 | 881 | 36.9 | 2,351 | 33.6 | |||||
Body Mass Index (Kg/m 2 ) | 0.083 | ||||||||||||
Underweight (BMI < 18.0) | 106 | 4.6 | 117 | 5.1 | 128 | 5.4 | 351 | 5.0 | |||||
Normal weight (18.0 ≤ BMI < 25.0) | 1,221 | 52.7 | 1,175 | 51.2 | 1,164 | 48.8 | 3,560 | 50.9 | |||||
Overweight (25.0 ≤ BMI < 30.0) | 691 | 29.8 | 661 | 28.8 | 742 | 31.1 | 2,094 | 29.9 | |||||
Obese (BMI ≥ 30.0) | 299 | 12.9 | 342 | 14.9 | 351 | 14.7 | 992 | 14.2 | |||||
Self-sufficiency | < 0.001 | ||||||||||||
Total autonomy | 839 | 36.2 | 1,028 | 44.8 | 1,348 | 56.5 | 3,215 | 45.9 | |||||
Autonomy in some activities | 864 | 37.3 | 755 | 32.9 | 552 | 23.1 | 2,171 | 31.0 | |||||
Not self-sufficient | 614 | 26.5 | 512 | 22.3 | 485 | 20.3 | 1,611 | 23.0 | |||||
Nephropathy | < 0.001 | ||||||||||||
Renal vascular disease | 586 | 25.3 | 567 | 24.7 | 508 | 21.3 | 1,661 | 23.7 | |||||
Diabetic nephropathy | 575 | 24.8 | 527 | 23.0 | 525 | 22.0 | 1,627 | 23.3 | |||||
Glomerulonephritis | 204 | 8.8 | 182 | 7.9 | 190 | 8.0 | 576 | 8.2 | |||||
Cystic renal disease and familial nephropathy | 149 | 6.4 | 162 | 7.1 | 164 | 6.9 | 475 | 6.8 | |||||
Interstitial and toxic nephritis/pyelonephriti | 133 | 5.7 | 135 | 5.9 | 123 | 5.2 | 391 | 5.6 | |||||
Systemic disease | 82 | 3.5 | 58 | 2.5 | 70 | 2.9 | 210 | 3.0 | |||||
Renal malformation | 12 | 0.5 | 14 | 0.6 | 6 | 0.3 | 32 | 0.5 | |||||
Other nephropathies | 83 | 3.6 | 99 | 4.3 | 132 | 5.5 | 314 | 4.5 | |||||
Unknown | 493 | 21.3 | 551 | 24.0 | 667 | 28.0 | 1,711 | 24.5 | |||||
Comorbidity | |||||||||||||
Severe hypertension | 1,478 | 63.8 | 1,524 | 66.4 | 1,665 | 69.8 | 4,667 | 66.7 | < 0.001 | ||||
Heart disease | 854 | 36.9 | 862 | 37.6 | 859 | 36.0 | 2,575 | 36.8 | 0.548 | ||||
Diabetes | 605 | 26.1 | 661 | 28.8 | 690 | 28.9 | 1,956 | 28.0 | 0.054 | ||||
Peripheral vascular diseases | 359 | 15.5 | 351 | 15.3 | 327 | 13.7 | 1,037 | 14.8 | 0.168 | ||||
Cerebrovascular disease | 301 | 13.0 | 350 | 15.3 | 321 | 13.5 | 972 | 13.9 | 0.064 | ||||
COPD | 316 | 13.6 | 319 | 13.9 | 336 | 14.1 | 971 | 13.9 | 0.905 | ||||
Cancer | 227 | 9.8 | 236 | 10.3 | 296 | 12.4 | 759 | 10.8 | 0.009 | ||||
Thyroid disease | 138 | 6.0 | 153 | 6.7 | 230 | 9.6 | 521 | 7.4 | < 0.001 | ||||
Obesity | 138 | 6.0 | 165 | 7.2 | 198 | 8.3 | 501 | 7.2 | 0.008 | ||||
Lipid metabolism’s alteration | 151 | 6.5 | 153 | 6.7 | 166 | 7.0 | 470 | 6.7 | 0.826 | ||||
Liver disease | 84 | 3.6 | 82 | 3.6 | 86 | 3.6 | 252 | 3.6 | 0.995 | ||||
Motor deficit | 66 | 2.9 | 79 | 3.4 | 74 | 3.1 | 219 | 3.1 | 0.509 | ||||
Dementia and Psychiatric disease | 63 | 2.7 | 63 | 2.8 | 89 | 3.7 | 215 | 3.1 | 0.072 | ||||
Extrauremic anemia | 68 | 2.9 | 56 | 2.4 | 62 | 2.6 | 186 | 2.7 | 0.566 | ||||
Malnutrition | 35 | 1.5 | 53 | 2.3 | 50 | 2.1 | 138 | 2.0 | 0.129 | ||||
Drugs use | |||||||||||||
Diabetes drugs | 596 | 25.7 | 643 | 28.0 | 633 | 26.5 | 1,872 | 26.8 | 0.204 | ||||
Hypertensive drugs | 1,932 | 83.4 | 1,948 | 84.9 | 2,039 | 85.5 | 5,919 | 84.6 | 0.121 | ||||
Other cardiovascular drugs | 1,502 | 64.8 | 1,508 | 65.7 | 1,550 | 65.0 | 4,560 | 65.2 | 0.799 | ||||
Anti-anaemic drugs | 2,072 | 89.4 | 2,041 | 88.9 | 2,115 | 88.7 | 6,228 | 89.0 | 0.708 | ||||
Vascular access | < 0.001 | ||||||||||||
CVC | 988 | 42.6 | 1,117 | 48.7 | 1,258 | 52.8 | 3,363 | 48.1 | |||||
FAV | 1,329 | 57.4 | 1,178 | 51.3 | 1,127 | 47.3 | 3,634 | 51.9 | |||||
Type of dialysis centre | < 0.001 | ||||||||||||
Public | 1,238 | 53.4 | 1,100 | 47.9 | 1,228 | 51.5 | 3,566 | 51.0 | |||||
Private | 1,079 | 46.6 | 1,195 | 52.1 | 1,157 | 48.5 | 3,431 | 49.0 | |||||
Pre-dialysis counselling | < 0.001 | ||||||||||||
Yes | 1,808 | 78.0 | 1,816 | 79.1 | 1,711 | 71.7 | 5,335 | 76.2 | |||||
No | 509 | 22.0 | 479 | 20.9 | 674 | 28.3 | 1,662 | 23.8 | |||||
Laboratory findings | mean [IQR] | mean [IQR] | mean [IQR] | mean [IQR] | p-value^ | ||||||||
HB (g/dL) | 10.4 [9.4–11.2] | 10.3 [9.4–11.2] | 10.2 [9.1–11.0] | 10.2 [9.1–11.0] | < 0.001 | ||||||||
Calcium (mg/dL) | 8.7 [8.2–9.2] | 8.7 [8.2–9.1] | 8.7 [8.2–9.1] | 8.7 [8.2–9.1] | 0.025 | ||||||||
Serum creatinine (mg/dL) | 7.0 [5.4–8.2] | 6.7 [5.1–7.9] | 6.8 [5.1-8.0] | 6.8 [5.1-8.0] | < 0.001 | ||||||||
Serum phosphate level (mg/dL) | 5.1 [4.2–5.9] | 5.0 [4-5.8] | 4.9 [4.0-5.7] | 4.9 [4.0-5.7] | < 0.001 | ||||||||
Serum albumin (mg/dL) | 3.7 [3.4-4.0] | 3.6 [3.3-4] | 3.5 [3.2–3.9] | 3.5 [3.2–3.9] | < 0.001 |